Clinical Trial: Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Nonalcoholic Steatohepatitis
Study Type: INTERVENTIONAL
Official Title: A Phase 1a/1b Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OA-235i, a PAR2 Inhibitor, in Adults With Nonalcoholic Steato
Brief Summary:
This study is a Phase 1, first-in-human single-dose escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of OA-235i in subjects with nonalcoholic steatohepatitis.
Read more